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Abstract
Transgenic rodents expressing Cre recombinase cell specifically are used for exploring mechanisms regulating behavior, 
including those mediated by cholinergic signaling. However, it was recently reported that transgenic mice overexpressing 
a bacterial artificial chromosome containing choline acetyltransferase (ChAT) gene, for synthesizing the neurotransmitter 
acetylcholine, present with multiple vesicular acetylcholine transporter (VAChT) gene copies, resulting in altered cholin-
ergic tone and accompanying behavioral abnormalities. Since ChAT::Cre+ rats, used increasingly for understanding the 
biological basis of CNS disorders, utilize the mouse ChAT promotor to control Cre recombinase expression, we assessed 
for similar genotypical and phenotypical differences in such rats compared to wild-type siblings. The rats were assessed for 
mouse VAChT copy number, VAChT protein expression levels and for sustained attention, response control and anxiety. Rats 
were also subjected to a contextual fear conditioning paradigm using an unconditional fear-inducing stimulus (electrical foot 
shocks), with blood samples taken at baseline, the fear acquisition phase and retention testing, for measuring blood plasma 
markers of hypothalamic–pituitary–adrenal gland (HPA)-axis activity. ChAT::Cre+ rats expressed multiple mouse VAChT 
gene copies, resulting in significantly higher VAChT protein expression, revealed anxiolytic behavior, hyperlocomotion and 
deficits in tasks requiring sustained attention. The HPA-axis was intact, with unaltered circulatory levels of acute stress-
induced corticosterone, leptin and glucose. Our findings, therefore, reveal that in ChAT::Cre+ rats, VAChT overexpression 
associates with significant alterations of certain cognitive, motor and affective functions. Although highly useful as an 
experimental tool, it is essential to consider the potential effects of altered cholinergic transmission on baseline behavior in 
ChAT::Cre rats.
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BAC  Bacterial artificial chromosome
BSA  Bovine serum albumin
5-CSRTT  Five-choice serial reaction time task
ChR2  Channelrhodopsin-2
ChAT  Choline acetyltransferase
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PCR  Polymerase chain reaction
PVDF  Polyvinylidene difluoride
PFC  Prefrontal cortex
qPCR  Quantitative PCR
RIPA  Radioimmunoprecipitation assay
RT-PCR  Real-time PCR
RRID  Research resource identifier
RT  Room temperature
SLC5A7  Solute carrier family 5 member 7
SD  Stimulus duration
TBS-T  Tris-buffered saline-Tween 20
TH  Tyrosine hydroxylase
VAChT  Vesicular acetylcholine transporter
Wt.  Wild-type
Introduction
Central cholinergic signaling is required for regulating 
aspects of memory, motivation and mood. On the other 
hand, cholinergic deficiency contributes to the neuropsy-
chiatric symptoms associated with Alzheimer’s disease 
(AD), with cholinomimetic therapies that may ameliorate 
such symptoms (Felder et al. 2018). In addition, although 
the main motor deficits characterizing Parkinson’s disease 
(PD) patients stem from the near total loss of midbrain dopa-
minergic neurons, the concomitant loss and/or dysfunction 
of cholinergic neurons is believed to underlie such patients’ 
cognitive decline (Perez-Lloret and Barrantes 2016; Bury 
et al. 2017). Hyperactivity of brain cholinergic systems could 
also underlie the cognitive disturbances observed in patients 
with affective disorders (Saricicek et al. 2012; Mineur et al. 
2013), while additional evidence for this derives from clini-
cal and preclinical studies which revealed that cholinergic 
receptor blockers can induce antidepressant-like responses 
(Furey and Drevets 2006). Furthermore, increasing data 
from clinical pharmacology, neuroimaging and postmortem 
studies implicates the cholinergic system in the pathogenesis 
of schizophrenia (Sarter et al. 2012). Conversely, growing 
evidence suggest that pharmacologically increasing cho-
linergic signaling could improve several symptom clusters, 
including visual hallucinations, in schizophrenia patients 
(Foster et al. 2012). However, despite the accumulating 
evidence in support of cholinergic perturbations as an etio-
logical factor in several neuropsychiatric human diseases, 
patients remain mostly unresponsive to current cholinergic-
based pharmacological therapies. This highlights a need for 
establishing appropriate mammalian models for understand-
ing the cholinergic roots of these disorders and for in vivo 
validation of candidate therapeutics that are potentially more 
effective treatments, by specifically correcting the relevant 
pathophysiological mechanisms.
For modeling human disease, rats offer several distinct 
advantages over mice and other organisms. Benefits include 
increased spatial resolution due to rats’ larger sized heads, 
which provides practical advantages for performing surgi-
cal procedures, including intracerebral cannula implantation 
for localized drug infusion into a specific brain region, to 
determine the role of this region in a particular behavioral 
phenotype (Kokare et al. 2011). Proportionally, larger brain 
substructure sizes also lends itself to more precise implanta-
tion of microdialysis probes for sampling neurotransmitter 
concentrations, as the cannula causes less damage by affect-
ing smaller regions. Although mice continue to offer distinct 
advantages over rats for precise targeting of gene expres-
sion to defined neuronal populations (Taniguchi et al. 2011; 
Madisen et al. 2012; Gerfen et al. 2013), tremendous strides 
made in developing a toolbox of transgenic rat lines have 
allowed for unprecedented interrogation of cell type-specific 
neural populations and -circuits. Such experimental strides 
are permitted by engineering cell-specific targeting in a Cre 
recombinase-dependent manner, along with advances made 
in engineered viral vectors. These transgenic rat technolo-
gies can be combined with opsin- and Designer Receptors 
Exclusively Activated by Designer Drugs (DREADDs), for 
untangling the neural substrates of a wide plethora of behav-
iors; these are beginning to be tapped in research studies 
(e.g., Sharma and Pienaar 2014, 2018).
Choline acetyltransferase (ChAT)::Cre+ transgenic rats, 
utilizing bacterial artificial chromosome (BAC) recombineer-
ing for introducing a transgene of interest under control of 
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cholinergic neuronal-specific promoter elements (Witten et al. 
2011) were generated to genetically restrict expression of Cre 
recombinase in cholinergic neurons. As an additional genetic 
element, the BAC is inserted within the genome, sometimes 
in multiple copies, with the original ChAT locus that remains 
intact.
Such rats are extremely useful in promoting understand-
ing of cholinergic circuits (Aldrin-Kirk et al. 2018; Dautan 
et al. 2014, 2016; Gielow and Záborszky 2017) including their 
role in motor function and reward-related behaviors during 
both homeostatic and disease processes (Pienaar et al. 2015; 
Dautan et al. 2016; Xiao et al. 2016). The generation of these 
transgenic rats followed on from work using transgenic mice 
was designed to encode channelrhodopsin-2 (ChR2) protein 
under the control of the ChAT promoter (Heintz 2001). This 
design largely ignores the tandem gene arrangement for the 
cholinergic gene locus (Prado et al. 2017), where the gene 
for the vesicular acetylcholine transporter is nested within the 
first intron of the ChAT gene. Evidence is accumulating that in 
ChAT::Cre+ rodents, altered expression of the gene encoding 
for the vesicular acetylcholine transporter (VAChT), which 
serves as a key molecular component of acetylcholine (ACh) 
release by loading ACh molecules into the synaptic vesicles 
of cholinergic synapses, could modify baseline cholinergic 
tone. This modification could provide a mechanistic basis for 
changing aspects such as locomotion, operant conditioning, 
spatial and working memory, attention, as well as intravenous 
nicotine self-administration behaviors, as had been reported for 
ChAT-ChR2-eYFP BAC transgenic mice, compared to wild-
type (Wt/Wt) and hemizygous (Tg/Wt) littermates (Kolisnyk 
et al. 2013; Sugita et al. 2016; Chen et al. 2018; Janickova 
et al. 2017).
Here, we determined the mRNA and protein expres-
sion levels of VAChT in ChAT::Cre+ rats compared to Wt 
(ChAT::Cre−) ones, to gain mechanistic understanding as to 
the influence exerted by altered expression of cholinergic sign-
aling factors in performance in the five-choice serial reaction 
time task (5-CSRTT), a well-validated measure of attention 
and impulsivity (Robbins 2002). We further conducted motor 
and anxiety profiling in the transgenic rats compared to their 
Wt littermates, using a range of well-validated behavior tests. 
Due to compelling evidence that the cholinergic system plays a 
role in stress and, specifically in hypothalamic–pituitary–adre-
nal gland (HPA)-axis activation and regulation, we also deter-
mined whether ChAT::Cre+ rats manifest a dysregulation of 
this endocrine control system (Paul et al. 2015).
Materials and methods
Animals
The animal experiments were approved by an ethics panel 
at Northumbria University (Ref: BMS39UNNGB2015) 
and were performed in accordance with the Animals (Sci-
entific Procedures) Act, 1986 (UK) for the care and use 
of experimental animals as well as the European Com-
munities Council Directive (2010/63/EEC). All rats were 
examined weekly by a veterinarian and constantly moni-
tored by experienced animal technicians for signs of pain 
or distress. Long-Evans Wt rats [Charles River, Kent, UK; 
Research Resource Identifier (RRID): RGD_2308852] 
were bred with hemizygous Long-Evans ChAT::Cre rats 
(Missouri Mutant Mouse Regional Resource Centre, 
University of Missouri, USA; RRID: RGD_10401204); 
both providers supplied up-to-date authentication reports. 
Once weaned, ear clippings were taken from each pup 
and analyzed for the Cre recombinase gene using poly-
merase chain reaction (PCR). The primers used were as 
described by Witten et al. (2011) and consisted of AAG 
AAC CTG ATG GAC ATG TTC AGG GATCG (forward) and 
CCA CCG TCA GTA CGT GAG ATA TCT TTA ACC (reverse), 
which produced a positive band corresponding to 600 base 
pairs. The PCR cycling conditions were similar to those 
described by Witten et al. (2011).
Only mature male rats (weight: 270–310 g) were used 
in the experiments to minimize gender and hormonal influ-
ences on behavior (Keeley et al. 2015). As an additional 
control condition for analyzing mouse VAChT gene copy 
number, brain tissue was also collected from male litter-
mate Wt control mice (weight: 25–30 g, on the C57BL/6 
background, received from Charles River, UK).
Animals were housed in groups of 3–4 per cage in poly-
propylene cages measuring 56 × 38 × 22 cm (RC2F; North 
Kent Plastics Cages, Coalville, UK) within an animal care 
facility at the University of Cambridge, in a temperature 
(23  °C) and humidity (45–65%) controlled room with 
a reversed light/dark cycle (lights off between 7:00 and 
19:00 h). The behavioral experiments were carried out at 
the same time each day, during the dark period which rep-
resents the rats’ nocturnal phase of the circadian cycle, 
during which they experience their most active, inquisitive 
and responsive period (Gorka and Adamik 1993). As the 
rats were maintained on a reverse light/dark cycle, this 
enabled us to conveniently test the rats during their activ-
ity phase.
One group was used for testing in the 5-CSRTT 
(ChAT::Cre+, n = 13; ChAT::Cre−, n = 8), whilst the 
second group was subjected to anxiety-profiling tasks, 
consisting of the open field (OF) arena, elevated plus maze 
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(EPM), and light/dark box (LDB) (ChAT::Cre+, n = 8; 
ChAT::Cre−, n = 10). Finally, some of the rats (that had 
been subjected to either the 5-CSRTT or anxiety testing) 
were subjected to fear conditioning testing followed by 
blood/tissue analysis (ChAT::Cre+, n = 5; ChAT::Cre−, 
n = 8). During 5-CSRTT training, the animals had their 
weight monitored weekly and maintained at 85–95% of 
their free feeding body weight. During this period, the 
animals received 18 g of laboratory pellet chow once a day 
with ad libitum access to water. Animals used for anxiety 
profile tasks and fear conditioning followed by blood/tis-
sue analysis had ad libitum access to food and water. OF, 
EPM, LDB, fear conditioning testing and blood sampling 
occurred between 14:00 and 17:00. The order of behav-
ioral assessment was anxiety profile tasks (OF, EPM and 
LDB) followed by the contextual fear conditioning task 
(CFCT) and then blood sampling. No sample calculation 
was performed to estimate the number of rats used in each 
experimental group.
Behavioral procedures
Blind scoring of the rats’ behavioral test performance was 
performed using automated computer software. Addition-
ally, the experimenter was blind to genotype during rat-
derived sample processing. For each behavioral test, rats 
were tested in a counterbalanced order with regard to geno-
type. Following testing of each animal, the apparatus was 
thoroughly cleaned with 70% ethanol (EtOH) to eliminate 
the residual odors and traces of the previously tested animal.
Open field testing
All behavioral procedures were conducted in a dark (visibil-
ity was 5 m), soundproofed room. For measuring behavior 
in the OF arena, rats were placed in the center of a circular 
field of 900 cm (diameter) × 38.5 cm (height). The apparatus 
consisted of an inner field (625 cm in diameter) surrounded 
by an outer field (375 cm from inner field edge to field’s 
edge). Room temperature (RT) and lighting were identical 
to that used for testing in the EPM (see below). Each rat 
was recorded for 5 min using a Yi Action Camera (Yi Tech-
nology, Seattle, USA) connected to a personal computer, 
with subsequent videos analyzed using ANY-maze software 
(Stoelting ANY-maze, Wood Dale, USA). Parameters were 
time spent in inner field (% of time), number of entries into 
inner field, distance traveled (m), number of bouts and time 
spent grooming (s), number of bouts and time spent rearing 
(s), and average speed (cm/s).
An animal was recorded to have entered either the inner- 
or outer field of the test area when all four paws had been 
placed inside either zone. The protocol stipulated that 
a rat would be excluded from analysis if a noise or other 
disruption occurred in the test environment, as a likely influ-
encer of the rat’s behavior.
Elevated plus maze testing
At least 7 days after conducting OF testing on the rats, the 
rats’ exploratory behavior in the EPM was recorded using 
the same recording equipment described above. The EPM 
was constructed from black and clear Perspex and consisted 
of two open arms (110 cm long × 11 cm wide) and two 
closed arms (110 cm long × 10 cm wide × 40 cm high), 
extending from a central platform, which was raised 50 cm 
from the ground. The testing room was illuminated evenly 
with white light (intensity 70 lx). The protocol was run as 
previously described (Walf and Frye 2007). Briefly, rats 
were placed facing the same open arm in the central platform 
and exploratory behavior was recorded for 5 min. Animals 
were excluded from analysis under the following conditions: 
when a rat fell over the edge of the open arms of the maze 
and if a noise or other disruption caused the rat to freeze 
during testing. The parameters analyzed were time spent in 
open arms (% of time), number of entries into open arms (n), 
distance traveled (m), number (n) and time spent grooming 
(s), number (n) and time spent rearing (s), and average speed 
(cm/s). ANY-maze software was used to analyze the videos.
The EPM testing protocol stated that entry into an arm 
was only scored when all four paws of the animal had 
entered an arm, while a rat that fell over the edge of the 
open arms of the maze or froze during testing due to a noise 
or other disruption would be excluded.
Light/dark box testing
Rodents prefer dark and enclosed places, as a strategy 
for reducing the risk of predation (Crawley and Goodwin 
1980). With this regard, the LDB assay has been deemed 
an ethologically relevant measure of anxiety-like behavior 
in rodents as it assesses approach versus avoidance behav-
ior, baseline vigilance and defensive behaviors (Lezak et al. 
2017). Both groups of rats were subjected to an LDB test 
paradigm at least 7 days after completing testing in the EPM. 
We utilized an LDB apparatus similar to that described 
by Bourin and Hascoe (2003), consisting of a plastic box 
divided into two equally sized partitions: a light—(brightly 
lit with white walls) and dark (minimally lit with black 
walls) chamber. The chambers were divided by means of 
a Perspex partition containing an opening that was large 
enough for an adult male rat to transverse between the two 
chambers, with the opening that was covered by a sliding 
door. All ChAT::Cre+ and ChAT::Cre− rats were tested in 
the same testing box. Testing was performed in accordance 
with previously described procedures (Arrant et al. 2013). 
The test commenced with a rat placed in the dark half of 
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the box, with the sliding door that was raised simultane-
ously. Each animal’s behavior was recorded for 5 min using 
the recording equipment described above. Through the use 
of ANY-maze software, we analyzed the recordings for the 
parameters: (1) the latency to enter the light chamber, (2) 
total time spent in the light chamber and (3) the number of 
entries into the light chamber.
An entry into either the light or dark chamber was scored 
when all four paws of the animal had been placed into the 
respective chamber to be considered an entry. The only 
exclusion criteria that had been preset were conditions of 
unforeseen loud noise or other disturbances, for which the 
protocol stated that a subject would then be removed from 
the analysis.
Five‑choice serial reaction time task
The 5-CSRTT is a well-validated task for assessment of sev-
eral cognitive functions and manifesting behaviors including 
vigilance, impulsivity and compulsivity (Bari et al. 2008). 
Training and testing took place in Bussey-Saksida Touch 
System chambers (Lafayette Instrument, Indiana, USA) net-
worked to a computer using ‘Whisker’ software. Chambers 
were trapezoidal [30 cm (height) × 35 cm (length) × 30 cm 
front end (width) × 25 cm rear end (width)], with a touch-
sensitive liquid crystal display flat screen placed at the front 
end. A food magazine was placed at the rear end, into which 
45 mg reward sugar pellets (Sandown Scientific, Middlesex, 
UK) were dispensed from an external dispenser. Black per-
spex masks with five evenly spaced square apertures located 
basally in the rat’s immediate field of vision were secured in 
front of the touch screens. Infrared sensors were located at 
the front and rear of the chamber.
Briefly, animals were trained to nose-poke into one of 
five briefly illuminated apertures, spaced randomly. The 
baseline and training task ended after 30 min or when ani-
mals had completed 100 trials. A stimulus duration (SD) of 
0.5 s is standard for 5-CSRTT when assessing rats. However, 
behavioral output was largely below criteria (≥ 70% accu-
racy and ≤ 20% omissions) at an average SD of 0.5 s, so an 
SD of 0.6 s was instead utilized as the baseline level. Four 
ChAT::Cre+ and two ChAT::Cre− animals were excluded 
from further testing due to failure to reach final criteria. 
After establishing that baseline criteria were consistently 
met, rats were assessed using a varied SD probe (0.15, 0.3 
and 0.6 s). Variables recorded at each session included: (1) 
correct responses; (2) incorrect responses; (3) accuracy 
(number of correct responses divided by the total of cor-
rect and incorrect responses, expressed as a percentage); (4) 
omitted responses; (5) premature responses [responses made 
during intertrial interval (ITI)]; (6) perseverative responses 
(repeat responses made after a correct response); (7) correct 
response latency (time from stimulus presentation until a 
correct response was made); (8) incorrect response latency 
(time from stimulus presentation until an incorrect response 
was made); and (9) magazine latency (time to collect reward 
post-correct response).
Although environmental noise was kept to a minimum, 
the 5-CSRTT protocol stated that in case of an unexpected 
noise or other disturbance occurring during 5-CSRTT test-
ing, a rat affected would be removed from analysis.
Animal killing and tissue handling for molecular 
analyses
At the end of the behavioral assessments, the rats were 
killed humanely by exposure to  CO2 and the heads were 
decapitated. The brains were rapidly removed from the 
skull, immediately followed by bilateral microdissection 
of the prefrontal cortex (PFC) brain tissue on a prechilled 
metal plate. All dissection instruments were prechilled in 
powdered dry ice. The specimens were then flash frozen in 
liquid nitrogen and stored at − 80 °C until further use within 
labeled tubes that were immediately sealed. All steps in the 
procedure were performed rapidly to avoid RNA and protein 
degradation.
Contextual fear conditioning task
The CFCT is a well-validated behavioral assessment meas-
ure that is used for exploring the neural substrates involved 
in emotional learning and memory (Tavote et al. 2015; Kim 
and Jung 2006). Here, we utilized this Pavlovian condition-
ing task to monitor HPA-axis functioning in ChAT::Cre+ 
compared to ChAT::Cre− rats, by measuring levels of blood 
plasma markers to an acute stressor. Acquisition and reten-
tion testing took place in operant conditioning chambers 
(Med Associates, Vermont, US) measuring 30.5 cm (length) 
× 32.5 cm (height) × 24.1 cm (wide), with a plexiglass 
door and ceiling and metal paneling on the back and on the 
sides. The floor of the chamber consisted of a metal grid 
through which a mild electrical shock (115 VAC, 60 Hz; 
ENV-224AMWN, Med Associates) was delivered. Testing 
chambers were placed in sound and light attenuating boxes 
that had been networked to a computer using ‘Whisker’ 
software (Campden Instruments Ltd., Loughborough, UK) 
(Cardinal and Aitken 2010). On the day of training, each 
rat was placed in the chamber for 3 min, during which time 
it received no stimulation or cues. At the end of the third 
minute, rats received 3× 1 s foot shocks of 1 mA intensity 
with 60 s intershock intervals. Animals were removed 30 s 
after the final foot shock, which placed acquisition dura-
tion at 330 s. Retention testing took place 24 h later, with 
each animal being placed in their respective chamber and 
their behavior recorded for 8 min. Freezing behavior (lack 
of movement, except for breathing) was analyzed using 
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Matlab software (MathWorks, Massachusetts, US). Blood 
plasma samples were collected from each rat to represent 
the baseline, acquisition and retention phases of the CFCT, 
with procedural details provided below.
Blood plasma analysis of corticosterone, leptin 
and glucose levels
Blood was taken sublingually under general anesthesia (5% 
isoflurane). Baseline samples were collected 2 days prior 
to initiating the task protocol, at the same time of day that 
blood would be collected on contextual fear conditioning 
testing days, which occurred 25 min post-acquisition train-
ing and also the same length of time post-retention testing. 
Approximately, 1 ml samples were taken using ethylen-
ediaminetetraacetic acid (EDTA)-primed vials (Thermo 
Fisher Scientific, UK), which were then placed on ice and 
centrifuged at 3000×g at 4 °C for 20 min. Plasma was ali-
quoted into Eppendorf tubes for corticosterone level analy-
sis. Corticosterone (Cat No. ADI-901-097, Enzo Life Sci-
ences, Devon, UK; RRID: AB_2307314) and leptin (Cat No. 
ADI-900-015A, Enzo Life Sciences, UK) quantification was 
done using enzyme-linked immunoassay (ELISA) kits with 
glucose quantification that was done using a colorimetric 
assay kit (Cat No. 10009582, Cayman Chemical, Michigan, 
USA), all according to the manufacturer’s instructions. The 
plasma corticosterone and leptin concentration levels are 
given as ng/ml, while glucose plasma concentration is given 
as mg/ml.
Quantitative RT‑PCR
To examine the copy number of mouse VAChT transgene, we 
used primers specific for the mouse VAChT gene (VAChT-
intron forward: GAG AGT ACT TTG CCT GGG AGGA and 
VAChT-intron reverse: GGC CAC AGT AAG ACC TCC 
CTTG) and actin primers (actin forward: TAT CCT GGC 
CTC ACT GTC CA and actin reverse: AAG GGT GTA AAA 
CGC AGC TCA), for normalization. Actin primers were able 
to efficiently amplify both mouse and rat genes. Both primer 
pairs showed efficiency above 95% and similar amplified 
fragment size. We compared amplification of Cre+ rat DNA 
to Cre− rat DNA and also mouse DNA. Briefly, DNA was 
isolated from either rat (ChAT::Cre+, n = 5; ChAT::Cre−, n 
= 8) or mouse (n = 4) PFC brain tissue samples that had been 
pooled according to the genotype, using the phenol–chloro-
form extraction protocol (Guzman et al. 2011), precipitated 
with isopropanol and washed twice on 70% EtOH. The DNA 
pellet was dissolved in ultra-pure water and concentration 
was determined based on Nanodrop measurements. PCR 
reaction was prepared using the Sensifast SYBR Green kit 
(Cat No. BIO-98020, Bioline, UK). We used a 10-μl total 
volume, with each primer at concentration of 200 nM and 
a genomic DNA concentration of 10 ng. Technical tripli-
cates were applied and melting curve was checked for each 
run. Quantitative PCR (qPCR) was performed, using the 
C1000TM Thermal Cycler, CFX96 Real-Time System 
(Bio-Rad) at the following settings: step 1: 95 °C for 5 min; 
step 2: 95 °C for 30 s; step 3: 60 °C for 10 s; step 4: 72 °C 
for 10 s; step 5: plate reading. Steps 2–5 were repeated 40 
times. Copy number of mouse VAChT transgene in rats was 
determined by the  2−ΔΔCq method (Livak and Schmittgen 
2001). The mean Cq of the mouse VAChT gene and the mean 
Cq of actin gene in the ChAT::Cre+ and ChAT::Cre− rats 
were calculated with fold-change that was determined using 
the  2−ΔΔCq method. One group was used for testing in the 
5-CSRTT (ChAT::Cre+, n = 13; ChAT::Cre−, n = 8), whilst 
the second group was subjected to anxiety-profiling tasks, 
consisting of the OF arena, EPM and light/dark box (LDB) 
(ChAT::Cre+, n = 8; ChAT::Cre−, n = 10).
For quantifying VAChT mRNA expression, total RNA 
was isolated using the Aurum Total RNA Fatty and Fibrous 
Tissue Kit (Cat no. 7326830, Bio-Rad, Hercules, CA, USA), 
in accordance with the manufacturer’s instructions, using 
the remainder of the genotype-pooled rat PFC samples 
(ChAT::Cre+, n = 5; ChAT::Cre−, n = 7). cDNA was syn-
thesized using a High Capacity cDNA reverse transcription 
kit (Thermo Fisher Scientific, UK), again following the man-
ufacturer’s manual. cDNA was then diluted and the quantita-
tive Real-Time PCR (RT-PCR) reaction was performed on a 
C1000™ Thermal Cycler, CFX96 Real-Time System (Bio-
Rad) using Bioline Sensifast SYBR Green (BIO-98020) 
using the following PCR cycling conditions: step 1: 95 °C 
for 5 min; step 2: 95 °C for 10 s; step 3: 60 °C for 10 s; 
step 4: 72 °C for 10 s; step 5: plate reading, with steps 2–5 
repeated 40 times. The primer pairs were as follows: mouse 
VAChT-exon forward: CCC TTT TGA TGG CTG TGA , mouse 
VAChT-exon reverse: GGG CTA GGG TAC TCA TTA GA. Rat 
β-actin was used as reference gene for data normalization, 
as the actin primer can detect both rat and mice mRNA and 
genomic DNA. For detecting actin, the following primer 
pairs were used: rat β-actin forward: TAT CCT GGC CTC 
ACT GTC CA, rat actin reverse: AAG GGT GTA AAA CGC 
AGC TCA. Technical triplicates were applied and melting 
curve was checked, as a standard procedure for each plate.
Western immunoblotting
The PFC rat brain tissue samples, pooled according to 
genotype, were lysed using radioimmunoprecipitation 
assay (RIPA) lysis buffer, followed by separation of pro-
teins on 10% SDS-PAGE (sodium dodecyl sulfate-poly-
acrylamide) gels. Proteins were transferred to Immobilon-
P polyvinylidene difluoride (PVDF) membranes (Cat No. 
IPVH00010, Millipore, UK) using a semi-dry transfer appa-
ratus (Trans-Blot Turbo™, Bio-Rad) run at 20 V for 1 h. The 
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membrane was then blocked in 5% (w/v) powdered skimmed 
milk in Tris-buffered saline/0.1% Tween 20 (TBS-T) for 1 h, 
followed by incubation overnight at 4 °C with a primary 
antibody raised against α-VAChT (1:1000, rabbit polyclonal, 
Cat No. 139-103, Synaptic Systems, Göttingen, Germany; 
RRID: AB_10893979) diluted in blocking solution. The next 
morning, after washing 3× in TBS-T, the membrane was 
incubated with the secondary antibody for 1 h at RT. The 
membrane was then washed again in TBS-T before visual-
izing the signal using the ECL-plus kit (Cat No. RPN2236, 
GE Healthcare, UK) in the Bio-Rad Chemi-DocTm Imag-
ing system. Following such washes, the membrane was 
stripped and then probed for α-synaptophysin using a rabbit 
polyclonal antibody (1:2000, Cat No. 32594, Abcam, UK; 
RRID: AB_778204), dissolved in 5% bovine serum albumin 
(BSA)/TBS-T, as an internal loading control. Protein densi-
ties on Western blots were analyzed and quantified with v. 
1.45 s ImageJ software (http://image j.nih.gov/ij/; provided 
in the public domain by the National Institutes of Health, 
Bethesda, MD, USA).
Statistical analysis
All data are expressed as mean ± standard error of the mean 
(SEM). SPSS Statistics (v.22, IBM) software was used for 
statistical analysis of the data. The distribution of the data 
was examined using the D’Agostino–Pearson omnibus test. 
Mouse VAChT gene copies and VAChT protein comparisons 
between genotypes were analyzed using an independent Stu-
dent’s t test. A one-way ANOVA followed by the Tukey’s 
multiple comparison test was used to analyze VAChT mRNA 
levels between ChAT::Cre+ rats, ChAT::Cre− (Wt) rats, and 
also Wt mice, which served as an additional control for the 
VAChT mRNA measures. Corticosterone, leptin and glu-
cose data were analyzed a using mixed-effects ANOVA with 
time-point being the within-subjects factor and genotype the 
between-subjects factor. Freezing scores for fear condition-
ing and all anxiety profile task parameters were compared 
using an independent samples t test. Baseline 5-CSRTT data 
were analyzed in a mixed-effects ANOVA with session as 
within-subjects factor and genotype as between-subjects fac-
tor. The varied SD probe was analyzed similarly with ses-
sion and SD time as within subject and genotype as between 
subject factors. Any main effects were examined using the 
Tukey’s HSD (honestly significant difference) post hoc com-
parison, with interactions that were explored using a Fisher’s 
LSD (least significant difference) post hoc analysis; from 
both tools, the effect size (η2) was calculated. Any extreme 
outliers were identified using the ‘outlier labeling rule’ and 
removed from data analysis (Hoaglin et al. 1986). The rule 
entails that the difference between the lower and upper quar-
tile is multiplied by a factor ‘g’. Due to the published advice 
advising that the initially suggested ‘g’ value of 1.5 (Hoaglin 
et al. 1986) proved inaccurate in some instances and that a 
multiplier value of 2.2 generates valid results more often 
(Hoaglin and Iglewicz 1987), we utilized a ‘g’ value of 2.2 
to the datasets generated for the current project. p values 
were designated as: ***p < 0.001, extremely significant; 
**p ≤ 0.01, highly significant; *p ≤ 0.05, significant and p 
> 0.05, non-significant (NS).
Results
ChAT::Cre+ rats exhibit an anxiolytic‑like 
and hypermobile behavioral profile
Anxiety profiles were evaluated from assessing the rats’ 
behavior in the OF, EPM and the LDB. The behavioral 
time-line for anxiety profiling is shown in Fig. 1a. In the 
OF, ChAT::Cre+ rats displayed a hypermobility profile com-
pared to ChAT::Cre− siblings, with a significantly increased 
average traveling speed (***p = 0.0008) (Fig. 1b), a greater 
distance covered (**p = 0.0063) (Fig. 1c), as well as rear-
ing more often (***p = 0.0006) (Fig. 1d) and, relatedly, 
spending more time rearing (***p = 0.0006) (Fig. 1e). The 
ChAT::Cre+ also appeared anxiolytic by entering the inner 
diameter significantly more than ChAT::Cre− siblings (***p 
= 0.0002) (Fig. 1f), while also spending significantly more 
time within the inner field of the test arena, compared to the 
ChAT::Cre− rats (***p = 0.0002) (Fig. 1g).
Similarly, ChAT::Cre+ rats showed higher average speed 
of movement (*p = 0.014) (Fig. 2a) and covered more dis-
tance in the EPM than their ChAT::Cre− siblings (***p = 
0.0005) (Fig. 2b) over the entire 5 min that rats were tested 
in the EPM; these findings again suggested a general hyper-
locomotion profile. In this test, a similar trend was also seen 
to that in the OF test, for ChAT::Cre+ rats to rear more (**p 
= 0.0017) (Fig. 2c) and for longer (*p = 0.0134) (Fig. 2d) 
for the full testing period within the EPM, than was seen 
for ChAT::Cre− rats. ChAT::Cre+ rats’ general anxiolytic 
tendency was reinforced by displaying an increased ten-
dency to visit the open arms of the EPM more often than 
ChAT::Cre− rats (***p = 0.0006) (Fig. 2e) and spending 
significantly more time in the open arms of the maze (*p = 
0.0403) (Fig. 2f) compared to ChAT::Cre− rats.
In the LDB, ChAT::Cre+ rats entered the light cham-
ber significantly more frequently (*p = 0.0132) (Fig. 3a), 
exhibited greater average duration of time in the light 
chamber (*p = 0.0118) (Fig. 3b) and subsequently, also 
spent less time in the dark chamber of the test apparatus 
(*p = 0.0277) (Fig. 3c). Taken together, use of multiple 
experimental paradigms revealed that the ChAT::Cre+ rat 
model displays spontaneous locomotion and adaptation 
to a novel, anxiety-evoking environment that differs from 
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the baseline behavioral profile seen for non-transgenic lit-
termate rats of a similar strain.
None of the rats’ performance scores were excluded 
from the final analysis for the anxiety-profiling tasks, 
based on the exclusion criteria set for each behavioral 
measure (for a description of these, please see the “Mate-
rials and methods”). In addition, no animal died dur-
ing behavioral testing. Hence, data collected for all rats 
tested in the OF, EPM and LDB were included in the final 
analyses.
ChAT::Cre+ rats make more errors of omission and 
fewer perseverative responses than Chat::Cre− rats in the 
5-CSRTT.
Figure 4 summarizes the results of the behavior dis-
played by the two genotypes in the 5-CSRTT. No differ-
ences were detected between the two groups in terms of 
choice accuracy (p = 0.714, NS) (Fig. 4a), the number of 
correct responses (p = 0.105, NS) (Fig. 4b) or the number 
of incorrect responses (p = 0.814, NS) (Fig. 4c). Relatedly, 
the measures ‘mean delay to make a correct response’ (p 
= 0.364, NS) (Fig. 4d) or to make an incorrect response (p 
= 0.061, NS) (Fig. 4e) were also left unchanged between 
transgenic and non-transgenic rats. Furthermore, the meas-
ures ‘number of premature responses’ (p = 0.946, NS) 
(Fig. 4f) and ‘mean latency of reward collection follow-
ing a correct response’ (p = 0.308, NS) (Fig. 4g) were also 
Fig. 1  The rats’ behavior was 
assessed for 10 min in the OF 
arena to measure locomotion 
and anxiety-like behavior. a The 
timeline of the anxiety-related 
and locomotion test proce-
dures performed on the rats are 
shown; all rats performed the 
same behavioral tests in the 
order shown. To investigate 
the acute effect of foot shock at 
post-acquisition and post-reten-
tion stage on plasma corticoster-
one, leptin and glucose levels, 
blood samples were collected 
at the time-points shown, to 
compare to baseline levels. In 
the OF test, the behavioral pro-
file of ChAT::Cre+ rats (n = 8) 
differed from their ChAT::Cre− 
siblings (n = 10). Taken 
together, the parameters b aver-
age speed of movement, c total 
distance traveled, d number of 
rearings made and also e the 
time spent rearing during the 
test, indicated that ChAT::Cre+ 
rats were hypermobile. Other 
parameters like f number of 
entries into inner field and (g) 
time spent in the inner field, fur-
ther revealed that ChAT::Cre+ 
rats were in a mixed hypermo-
bile and anxiolytic state. All 
data are presented as the mean 
± SEM. *p ≤ 0.05, **p ≤ 0.01 
and ***p < 0.001, compared to 
ChAT::Cre− rats
3103Brain Structure and Function (2019) 224:3095–3116 
1 3
similar between ChAT::Cre+ and ChAT::Cre− rats. How-
ever, compared to their ChAT::Cre− siblings, ChAT::Cre+ 
rats made significantly more errors of omission (*p = 0.016, 
η2 = 0.373) (Fig. 4h), but fewer perseverative responses (**p 
= 0.006, η2 = 0.456) (Fig. 4i).
During a version of the 5-CSRTT, where the SD probe 
length was varied, a main effect of SD on accuracy was 
detected (**p = 0.002) (Fig. 5a) that featured as decreas-
ing accuracy as SD times became shorter. This effect was 
caused by the overall tendency of ChAT::Cre+ rats to 
make fewer correct responses (*p = 0.05) (Fig. 5b), imply-
ing more incorrect responses (**p = 0.009) (Fig. 5c) as the 
SD decreased, compared to ChAT::Cre− siblings. How-
ever, no significant interaction was detected between SD 
variation and genotype. Between-subject genotype analy-
sis showed that upon variable and, therefore, increased 
demand conditions, ChAT::Cre+ rats made fewer per-
severative responses compared to ChAT::Cre− ones 
(*p = 0.018, η2 = 0.410) (Fig. 5d). This was similar to 
baseline behavior, to indicate that this phenotypical dif-
ference could be regarded as robust. When comparing 
perseverative responses assessed for different SD times, 
this decrease was significant at the longest duration probe 
tested for, namely 0.15 s (**p = 0.005) (Fig. 5d). The ten-
dency for ChAT::Cre+ rats to omit more responses com-
pared to their baseline behavior was not seen in the varied 
SD probe (p = 0.287, NS) (Fig. 5e). Differences were also 
not seen between genotypes in the varied SD probe when 
Fig. 2  Anxiety-like behavior 
in the rats was further assessed 
in the EPM maze, where the 
task is based on an approach-
avoidance conflict and greater 
avoidance of the open arms is 
interpreted as an exhibition of 
higher anxiety levels. The find-
ings reflected those obtained for 
OF testing, with regards to both 
general ambulation and anxiety-
like behavior. Over the duration 
of the test (5 min), ChAT::Cre+ 
rats (n = 8) traveled on aver-
age at a greater speed and b 
covered a greater distance than 
the ChAT::Cre− rats (n = 10). 
Compared to ChAT::Cre− rats, 
ChAT::Cre+ ones also revealed 
hypermobility by making c 
significantly more rearing bouts 
and d spending more time rear-
ing. ChAT::Cre+ rats also made 
e more entries into the open 
arms of the EPM apparatus and 
f spent more time in the open 
arms than their ChAT::Cre− 
siblings, reflecting the general 
anxiolytic profile detected 
for the ChAT::Cre+ rats seen 
during testing in the OF. All 
data are presented as the mean 
± SEM. *p ≤ 0.05, **p ≤ 0.01 
and ***p < 0.001, compared to 
ChAT::Cre− rats
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number of premature responses were assessed (p = 0.389, 
NS) (Fig. 5f).
ChAT::Cre+ rats display a biologically intact stress 
response to an acute stressor in a CFCT paradigm
Previous studies showed that the cholinergic system could 
play a role in HPA activation and corticosterone levels 
(Newman et al. 2001; Paul et al. 2015). To investigate the 
effects of altered cholinergic modulation on physiological 
stress responses, we measured plasma levels of corticos-
terone at baseline and post-retention testing in the CFCT. 
With this regard, several studies have demonstrated a posi-
tive relationship between circulating corticosterone levels 
and contextual conditioning (Pugh et al. 1997; Thompson 
et al. 2004).
The level of freezing, measured during retention testing, 
did not show any significant difference between genotypes 
(p = 0.642, NS) and produced an average of ~ 90% for each 
group (Fig. 6a). When all rats were considered together, 
without accounting for genotype, a significant increase of 
corticosterone from baseline to fear acquisition was seen 
(*p < 0.05), and also when baseline levels were compared 
to levels reached at the retention phase of the CFCT (***p 
< 0.001) (Fig. 6b). However, this effect was independent of 
genotype (p = 0.618, NS), with no interaction seen between 
genotype × sample point either (p = 0.199, NS). Post hoc 
analysis revealed high statistical significance between dif-
ferential levels of circulating corticosterone levels from 
baseline to retention phase for ChAT::Cre− litter mates 
(***p < 0.001); however, a similar comparison made for 
ChAT::Cre+ rats proved non-significant (p = 0.057, NS) 
(Fig. 6b).
Analysis of plasma glucose levels revealed no significant 
difference between sample points (p = 0.196, NS), when 
comparing the genotypes (p = 0.095, NS) or at a sample 
point × genotype interaction level (p = 0.290, NS) (Fig. 6c). 
Analysis of leptin levels revealed no significant difference in 
main effect of sample point (p = 0.50, NS) or of genotype 
(p = 0.933, NS), while no significant interaction effect was 
observed either (p = 0.108, NS) (Fig. 6d).
Higher levels of VAChT mRNA and protein 
expression in ChAT::Cre+ rats compared to Wt rats
qPCR results revealed that all Long-Evans ChAT::Cre+ rats 
analyzed here contained two copies of the mouse VAChT 
gene relative to ChAT::Cre− rats (***p < 0.001) (Fig. 7a). 
Mouse VAChT mRNA was variable within individual rats, 
with some having levels similar to mouse controls (Fig. 7b). 
However, overall, the expression of mouse VAChT mRNA in 
ChAT::Cre+ rats achieved approximately 50% the levels of 
mouse controls (Fig. 7b), which indicates the expression of 
the mouse VAChT gene inserts in the rat genome. Supporting 
Fig. 3  The LDB is another 
conventional anxiety test that is 
based on the innate aversion of 
rodents to brightly illuminated 
areas, which was utilized to test 
unconditional anxiety responses 
in the rats. The ChAT::Cre+ 
rats (n = 8) showed a greater 
preference for the light compart-
ment of the box compared to 
their ChAT::Cre− siblings (n 
= 10). Behavioral parameters 
assessed were: a total number 
of entries made into the light 
chamber, b time spent in the 
light chamber and c latency 
time for rats to enter the light 
chamber. All data are presented 
as the mean ± SEM. *p ≤ 0.05, 
compared to ChAT::Cre− rats
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Fig. 4  Performance in the 
5-CSRTT assessed for differ-
ences in attention, impulsiv-
ity and cognitive flexibility 
between the transgenic and 
Wt rats. ChAT::Cre+ rats (n 
= 13) made significantly more 
omission errors and fewer 
perseverative responses than 
their ChAT::Cre− siblings (n 
= 8) during 5-CSRTT testing, 
which measured the following 
parameters: a choice accuracy; 
b average number of correct 
responses; c average number of 
incorrect responses; d latency 
to make a correct nose poke 
response following stimulus 
presentation; e latency to make 
an incorrect response following 
stimulus presentation; f average 
number of premature responses; 
g latency to collect sugar pellet 
reward from food magazine 
after a correct response; h aver-
age number of errors of omis-
sion and i average total number 
of perseverative responses. All 
data are presented as the mean 
± SEM. *p ≤ 0.05, **p ≤ 0.01, 
compared to ChAT::Cre− rats
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the gene copy and the mRNA analysis, VAChT protein lev-
els were increased close to 50% in ChAT::Cre+ rats when 
compared to Cre− siblings (**p = 0.004) (Fig. 7c). This 
result supports the notion that the increased VAChT expres-
sion found in ChAT::Cre+ rats may also increase ACh levels 
within synaptic vesicles, as had previously been reported for 
BAC transgenic mice that express channelrhodopsin protein, 
a light-gated ion channel, under control of the ChaT pro-
moter (Sugita et al. 2016).
Discussion
The current findings show that, compared to their Wt sib-
lings, Long-Evans ChAT::Cre+ rats exhibit altered baseline 
behavior, affecting gross locomotor function, anxiety-related 
behavior as well as some aspects of sustained attention. We 
also molecularly analyzed the PFCs collected from the 
rats, with this brain region that receives dense cholinergic 
innervation and also connects directly and indirectly via 
cholinergic projection neurons with multiple brain areas, to 
provide important modulation of cortical function (Bloem 
et al. 2014; Tingley et al. 2015). The analysis revealed that 
these behavioral changes were paralleled by altered expres-
sion of VAChT within the PFC, at both a gene and protein 
level, with VAChT being a key molecular mechanism in 
the transport machinery of ACh from the cytoplasm to the 
lumen of synaptic vesicles, to ultimately release ACh into 
the synaptic cleft. Physiologically, an increase in levels of 
this functional transporter could alter ACh levels at the syn-
apse (Kolisnyk et al. 2013; Sugita et al. 2016; Nagy and 
Aubert 2012), which could alter cholinergic tone and, sub-
sequently, behavioral phenotype in rodents. Hence, the cur-
rent findings demonstrate that expression of the ChAT-BAC 
construct makes these rats different from their Wt siblings, 
similar to findings previously reported using BAC transgenic 
Fig. 5  A version of the 
5-CSRTT, where SD length 
was varied (0.6, 0.3 and 0.15 s), 
further measured attentiveness, 
impulsivity, processing speed 
and distractibility in the rats. 
SD length variance exerted an 
overall significant effect on a 
choice accuracy. This was since, 
compared to ChAT::Cre− rats 
(n = 8), the ChAT::Cre+ ones 
(n = 13) made on average, b 
less correct responses and, 
therefore, c more incorrect 
responses, as SD decreased. 
d ChAT::Cre+ rats made 
less perseverative responses 
compared to ChAT::Cre− ones, 
with the number of persevera-
tive responses that decreased 
most significantly at the longest 
duration probe, namely 0.15 s. 
e As detected in the stand-
ard 5-CSRTT, a tendency by 
ChAT::Cre+ rats to omit more 
responses compared to baseline 
behavior was not repeated. f 
Groups revealed similar levels 
of premature responses. All data 
are presented as the mean ± 
SEM. **p ≤ 0.01, compared to 
ChAT::Cre− rats
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mice engineered to express a light-sensitive protein under 
control of the ChAT promoter (Kolisnyk et al. 2013; Chen 
et al. 2018).
As was reviewed by Prado et al. (2013), ACh synthesis 
depends on the uptake of the ACh precursor, choline by 
CHT1 [high-affinity choline transporter/SLC5A7 (solute 
carrier family 5 member 7)] that mainly expresses within 
cholinergic neurons, yet presents in certain non-neuronal 
cells also. In the cytoplasm of synapses, ACh is then 
synthesized by the enzyme ChAT, with ACh that is then 
loaded into synaptic vesicles by VAChT. Upon arrival of 
a nerve impulse, the vesicles fuse to the plasma mem-
brane and release ACh that signal through nicotinic and 
muscarinic cholinergic receptors. ACh is rapidly degraded 
into acetate and choline by the enzyme AChE (acetylcho-
linesterase). In the current work, we have only evaluated 
expression levels of VAChT, in line with other studies uti-
lizing BAC transgenic mice for expressing a light-sensitive 
protein under control of the ChAT promoter that also 
restricted molecular analysis to VAChT, as a valid indica-
tor of cholinergic tone (Kolisnyk et al. 2013; Chen et al. 
2018). The importance of functional vesicular storage 
and synaptic “loading” of ACh, which is modulated by 
VAChT, acts as a required step for ACh release. In addi-
tion, decreased VAChT expression has been shown to lead 
to several motor and cognitive dysfunctions (Prado et al. 
2006; Martyn et al. 2012), some of which was presently 
behaviorally evaluated for in the ChAT::Cre+.
To ensure a comprehensive understanding of the levels 
at which altered cholinergic metabolism and transmission 
might be altered as a result of the ChAT::Cre+ genotype, 
future work should undertake gene and protein expres-
sion analysis of other important mediators in this process, 
including but not limited to ChAT, CHT-1, AChE, but also 
muscarinic and nicotinic receptors for signaling ACh. Such 
eventual comprehensive profiling will inform greatly on the 
Fig. 6  Freezing behavior and blood plasma analysis of HPA-axis bio-
markers performed on ChAT::Cre+ (n = 5) and ChAT::Cre− (n = 8) 
rats at baseline (2 days before initiating the task protocol), with test-
ing that was then repeated at the fear acquisition and fear retention 
stages of a CFCT. a Freezing scores acquired for retention testing; 
b comparison of corticosterone blood plasma levels between geno-
types at the different CFCT testing phases; c a similar comparison 
made for glucose blood plasma levels and for d leptin blood plasma 
levels. The significant increase in blood plasma corticosterone lev-
els seen in both rat genotypes from baseline to a repeat analysis soon 
after rats completed the fear acquisition and also the fear retention 
test phases, indicates that all rats of this strain, regardless of the geno-
type (ChAT::Cre+ vs. Wt), respond in a biologically intact manner to 
aversive conditioning. All data are presented as the mean ± SEM. *p 
≤ 0.05 and ***p < 0.001, compared to both genotype rats’ baseline 
measurements
3108 Brain Structure and Function (2019) 224:3095–3116
1 3
design of experimental work involving this popular experi-
mental rat tool.
Our data indicated a hypermobile state for ChAT::Cre+ 
rats over Wt ones in several parameters assessed in the OF, 
EPM and LDB. The observed locomotor arousal in the trans-
genic rats is consistent with the previously proposed mech-
anism that instantaneous ACh synaptic release correlates 
positively with increased activity by rodents seen in novel 
environments (Mizuno et al. 1991; Cohen et al. 2012), while 
ACh is known to fulfill a complex role in locomotor control, 
which includes modulating the dopaminergic system (Rice 
and Cragg 2004). Confirmation of the specific mechanisms 
for the observed hyperactive spontaneous activity awaits 
brain region-specific VAChT overexpressing rat models.
This result differs from those presented by Azzopardi 
et al. (2018) who observed no hyperlocomotive phenotype 
in ChAT::Cre+ rats, although enhanced motor endurance 
had previously been reported for the ChAT-ChR2-eYFP 
(enhanced Yellow Fluorescent Protein) BAC transgenic 
mouse line (Kolisnyk et al. 2013). It is worth noting though 
that the study by Azzopardi et al. (2018) made use of a 
single metric (distance traveled) for assessing abnormal 
mobility, with the group using a 45 × 45 cm square OF box. 
Instead, we made use of a circular test apparatus, with the 
shape of OF arena (circular, square or rectangular) that has 
been identified as an important variable that can influence 
OF performance by rodents (Sestakova et al. 2013). Simi-
larly, this research group only assessed the time spent in the 
outer perimeter in the same apparatus as indicator of anxiety. 
Lastly, Azzopardi et al. (2018) utilized rats in the experi-
mental procedures at a slightly older age, at 10–14 weeks, 
whereas rats used in the current study ranged between 8 
and 10 weeks of age. However, Long–Evans rats are con-
sidered to have reached adulthood by 8 weeks of age (Sny-
der et al. 2009; Jackson et al. 2016), while the age ranges 
of rats used in the present work do overlap somewhat with 
Fig. 7  Measurement of pre-
frontal cortical VAChT mRNA 
and protein levels. a qPCR 
results indicated additional 
mouse VAChT gene copies in 
all ChAT::Cre+ rats (n = 5) 
compared to ChAT::Cre− con-
trols (n = 8). This translated 
to b increased mouse VAChT 
mRNA expression in Cre+ (n 
= 5) and Cre− (n = 7) siblings 
compared to Wt mice (n = 4) 
and also c increased VAChT 
protein expression in PFC brain 
samples of Cre+ (n = 5) and 
Cre− (n = 8) rats. All data 
are presented as the mean ± 
SEM. *p ≤ 0.05, **p ≤ 0.01 
and ***p < 0.001, compared to 
ChAT::Cre− rats and Wt mouse
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that of the study by Azzopardi et al. (2018), allowing for 
reasonable confidence that the differences in experimental 
outcomes between these two studies is likely and at least not 
exclusively due to age-related differences. However, differ-
ences in the age of experimental rats have been highlighted 
as a potentially critical experimental variable, to especially 
account for changes in neurotransmitter release and receptor 
activation, that appear to alter substantially, especially over 
early stages of development (McCutcheon and Marinelli 
2009). Considering the differences in testing conditions 
and the characteristics of the experimental rats used in the 
current study compared to those used by Azzopardi et al. 
(2018), we conclude that our ambulation and anxiety results 
may not be directly comparable.
Our results also reveal ChAT::Cre+ rats to be anxiolytic, 
as was assessed in three frequently used tests of anxiety-like 
behavior, with such tests that consistently demonstrate the 
ability to reveal anxiolytic or anxiogenic profiles of rodents 
using either pharmacological- or transgenic manipula-
tions (Crawley 1985; Belzung and Griebel 2001; Prut and 
Belzung 2003). This result suggests that modest levels of 
VAChT overexpression at both the gene and protein level, 
previously shown to increase ACh release and, therefore, 
render animals hypercholinergic (Sugita et al. 2016; Jan-
ickova et al. 2017), associate with an anxiolytic behavioral 
profile in the ChAT::Cre+ rats. The findings reflect those 
from another hypercholinergic mouse model that also over-
expresses VAChT at the gene and protein level, with such 
mice that showed enhanced exploration of novel environ-
ments and, therefore, anxiolytic-like behavior, when com-
pared to C57BL/6J (B6) control mice (Nagy and Aubert 
2013). In this work, use was made of the B6eGFPChAT 
congenic mouse model that contains four genomic copies of 
the cholinergic gene locus, which encompasses the promoter 
and coding regions of both VAChT and ChAT (Tallini et al. 
2006; Nagy and Aubert 2012). As earlier work demonstrated 
increased VAChT gene and protein expression in congenic 
B6eGFPChAT mice (Nagy and Aubert 2012), this experi-
mental model allows for evaluating whether increasing the 
vesicular storage and release of ACh is sufficient for eliciting 
changes in behavioral activity.
Relatedly, previous studies showed that exposure to novel 
stimuli (i.e., novel environments) associates with cholinergic 
activation and increased ACh release (Thiel et al. 1998; Gio-
vannini et al. 2001), while others showed that modulation 
of central cholinergic systems regulate emotional processes 
including anxiety and stress (Podhorna and Franklin 1999, 
2000; Janickova et al. 2019). However, the effects of ACh on 
anxiety-like behavior in rodents has proved complex, with 
increased ACh release that evoked both anxiolytic and anxi-
ogenic reactions (File et al. 1998, 2000), which may relate to 
brain region-specific configurations of ACh receptors (File 
et al. 2000; Labarca et al. 2001).
The cholinergic system has been shown to play an 
important role in attentional mechanisms. Selective lesion-
ing of the Ch5 cholinergic cell group of the pedunculo-
pontine nucleus (PPN) (Mesulam et al. 1984), a rostral 
brainstem nucleus, resulted in a deficit shown during tests 
assessing for sustained attention, which manifested as a 
significant decrease in the number of correct responses 
and an increase in response latency (Cyr et al. 2015). Simi-
larly, cholinergic-specific lesions made in rats to the Ch4 
cholinergic cell group located in the nucleus basalis mag-
nocellularis (NBMc), the rat homologue of the nucleus 
basalis of Meynert (NBM), by means of 192 IgG-saporin 
infusions, also produced attentional impairments along 
with decreased levels of ACh in the PFC (McGaughy et al. 
2002). Moreover, attentional impairments are deemed a 
core feature of AD and have been shown to be caused, 
at least in part, by damage sustained by the NBM, which 
undergoes significant neuronal loss during progressive AD 
(Ferreira-Vieira et al. 2016).
Kolisnyk et al. (2013) showed that BAC transgenic mice 
generated to express the light-gated ion channel, channel-
rhodopsin-2, under control of the ChAT promoter, with such 
animals that are frequently used for dissecting out the rela-
tive contribution of cholinergic circuits in behavior, display 
severe deficits in several domains of cognitive function, and 
that this may be due to VAChT overexpression seen in such 
mice. In particular, transgenic mice were impaired in tasks 
assessing the domains spatial and working memory. Interest-
ingly, Nagy and Aubert (2015) reported, using hypercholin-
ergic congenic B6eGFPChAT aged mice, improved spatial 
memory acquisition during testing in the Morris water maze, 
to reveal a consensus between VAChT overexpression and 
improved spatial navigation during normal aging. The study 
further demonstrated an association between the mice’s aug-
mented memory acquisition and enhanced dendritic ramifi-
cation of adult-born neurons seen in the hippocampus, and 
at progressive ages. Since cholinergic signaling was previ-
ously shown to contribute to the dendritic expansion of tar-
get neurons (Höhmann et al. 1991), the study by Nagy and 
Aubert (2015) supports a role for cholinergic input to the 
hippocampus as a mechanism underlying the formation of 
dendritic networks to support formation of spatial memories.
Kolisnyk et al. (2013) also reported that the transgenic 
mice exhibited significantly more premature responses dur-
ing the 5-CSRTT, a behavioral paradigm frequently used 
for evaluating attention and impulsivity in animal mod-
els. This result differed from our current findings, which 
did not detect a similar deficit for the transgenic rats when 
subjected to either the self-paced version of the 5-CSRTT, 
or when the SD was varied during testing. Interestingly, 
increased premature responding has been associated with 
depletion of another monoamine neurotransmitter, seroto-
nin (Fletcher et al. 2013; Humpston et al. 2013); hence, our 
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results seemingly agree that a cholinergic imbalance in the 
brain do not manifest as this 5-CSRTT parameter.
However, the construct ‘impulsivity’ encompasses vari-
ous dimensions, namely motor impulsivity which refers to 
acting without thinking, cognitive impulsivity referring to 
rapid decision taking and non-planning impulsivity, refer-
ring to a present orientation (Patton et al. 1995). Further-
more, 5-CSRTT performance differences have been reported 
to exist between mice and rats, including a strategy bias with 
rats that showed greater reliance on a temporal strategy than 
mice did, resulting in more guessing if their timing was poor, 
and manifesting as premature responses (Fletcher et al. 
2007). First, for validating whether differences exist between 
mice and rats in 5-CSRTT performance, the protocol should 
be standardized, including intertrial interval (ITI) lengths. 
Species differences in baseline neurotransmitter concentra-
tions could also play a role (Fitzgerald 2009). In addition, 
given the complexity of mechanisms underlying 5-CSRTT 
parameters, including impulsivity, it is unlikely that a single 
brain function abnormality would underlie species differ-
ences, calling for considering interacting neurochemistry 
systems as the plausible basis of the observed interspecies 
differences in 5-CSRTT performance.
Our results also show that ChAT::Cre+ rats make sig-
nificantly more errors of omission than their Wt siblings, 
although this effect did not persist when rats were tested with 
a variable attentional load as a result of shorter or longer it 
is. Although accuracy was unaffected between the transgenic 
and Wt rats, this arguably points at a deficit in sustained 
attention, since the ChAT::Cre+ rats showed an increase 
in omissions, while latency parameters were left largely 
unaffected. Multiple studies have suggested that choliner-
gic signaling, especially when mediated by α4β2 nicotinic 
acetylcholine receptors, underlies altered responses in this 
attentional parameter measured in the 5-CSRTT (Shoaib and 
Bizarro 2005; Semenova et al. 2007). However, again mul-
tiple interacting neuromodulatory systems might form the 
neurochemical substrate of this deficit, as several studies 
suggested that enhanced midbrain dopaminergic activity in 
rats influenced trial omissions, although the direction of the 
effect was unpredictable (Granon et al. 2000; Agnoli et al. 
2013; Boekhoudt et al. 2017). It has been suggested that 
the monoaminergic and cholinergic systems may play sepa-
rable roles in different aspects of performance controlled 
by the 5-CSRTT (Robbins 2002). In the case of response 
omissions, motivational factors have been deemed important 
for driving this behavioral change, and not merely atten-
tional deficits, with dopamine that plays an established role 
in reward-motivation behavior mechanisms (Salamone and 
Correa 2012).
We also found that ChAT::Cre+ rats made significantly 
fewer perseverative responses in the 5-CSRTT, with this 
parameter that is commonly utilized as a reference for 
compulsive behavior as well as cognitive inflexibility, 
defined as the inability to adapt to goal-directed behavior in 
response to changing environmental demands (Gilbert and 
Burgess 2008; Eagle and Baunez 2010). Deficits in the abil-
ity to flexibly update behavior are observed in various neuro-
logical and psychiatric conditions including PD (Cools et al. 
2001), obsessive-compulsive disorder (OCD) (Chamberlain 
et al. 2008), drug addiction (Everitt et al. 2007), attention 
deficit/hyperactive disorder (ADHD) (Rubia et al. 2009) and 
pathological gambling (Koehler et al. 2013). The balance 
of evidence suggests that the PFC and striatum, which form 
part of the portico–basal–thalamic circuit, co-modulate cog-
nitive flexibility, while a multitude of studies demonstrated 
that ACh transmission facilitates this process (Prado et al. 
2017). With this regard, several studies have shown that 
cortical cholinergic manipulations selectively affect aspects 
of this cognitive domain with PFC nicotinic receptors that 
appear to play an important modulatory role in this process 
(Allison and Shoaib 2013). For example, in old rats (Tait 
et al. 2013; Nikiforuk et al. 2015), rat models of schizo-
phrenia (Alexander et al. 2013), and in rats that sustained 
immunolesioning of the basal forebrain cholinergic neurons 
(Cutuli et al. 2009), systemic administration of cholinest-
erase inhibitors for augmenting cholinergic transmission, 
improved both reversal learning (learning an association 
exists between one stimulus (of a pair) and reward, to then 
learn a reverse association where a previously unrewarded 
stimulus is now rewarded) and attentional set-shifting (shift-
ing from one mental set to another) impairments. Additional 
experimental evidence emphasizes a role by prefrontal ACh 
in cognitive flexibility, in particular the critical role by PFC-
mediated cholinergic signaling in the initial inhibition of a 
previously learned strategy. Ridley et al. (1994) transplanted 
neocortices of marmosets with cholinergic-rich neural tissue 
some weeks after inducing bilateral excitotoxic lesions to the 
NBM, where animals showed intact reversal learning during 
a visual discrimination task. In addition, others showed no 
impaired acquisition in an operant discrimination task, but 
deficits in reversal learning, in rats that had received selec-
tive cholinergic lesioning of the NBMc (Cabrera et al. 2006). 
However, the role of cholinergic signaling and the synergis-
tic interaction between this neurochemical system and the 
PFC in mediating cognitive flexibility remains controver-
sial, with some authors reporting that ablation of basal fore-
brain cholinergic neurons does not impair reversal learning 
(McGaughy et al. 2008; Tait and Brown 2008). Additional 
participation in cognitive flexibility by ACh within other 
brain areas such as the hippocampus, basolateral amygdala 
and posterior parietal cortex also participate in cognitive 
flexibility (Prado et al. 2017) may explain these controver-
sies; however, the modulating role played by PFC ACh in 
this process is strengthened by a large number of studies 
showing that cholinergic depletion of different prefrontal 
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areas results in dissociable deficits in separate forms of 
cognitive flexibility. Optogenetic and chemogenetic tools 
to modulate neuronal activity levels promise to character-
ize the cholinergic circuits involved this and other cognitive 
domains and unravel the exact role of the PFC in the process. 
Genetically modified rodents, including ChAT::Cre+ rats as 
we assessed in the current study, compliment such cell- and 
circuit-modifying tools, by allowing cholinergic machinery 
to be spatially and temporally targeted. However, as our pre-
sent study demonstrates, behavioral results obtained from 
use of such animals should consider whether baseline behav-
ioral changes are due to a hypercholinergic phenotype.
Cholinergic tone has also been associated with several 
memory- and learning-related functions. In addition, cho-
linergic neurons of the PFC, which we dissected out in the 
rats for gene and protein analysis of VAChT, have been 
implicated as a modulator (via cholinergic signaling) of 
specific aspects of memory (Croxson et al. 2011). Hence, 
an important direction for future research is to characterize 
the extent and nature of memory-related impairments in this 
transgenic rat line.
Although the current work did not incorporate an exten-
sive evaluation of memory-related functions in the rats, a 
CFCT was included, where animals learn that certain envi-
ronmental stimuli predict aversive events. This classical, 
Pavlovian (respondent) conditioning model provides an 
interface between memory and emotion (LeDoux 2000). 
In this testing paradigm, we measured the frequency of a 
defensive reflex namely freezing, shown by the rats during 
the retention stage of the CFCT, with freezing response con-
sidered to provide a readout of memory that is dependent 
on the hippocampus, amygdala and PFC (McEchron et al. 
1998; Gilmartin and Helmstetter 2010; Kochli et al. 2015). 
Hence, as this assessment entails cognitive/explicit and non-
cognitive/implicit fear memory that are supported by neural 
pathways that converge, the CFCT rather assesses associa-
tive memory processes by testing a memory for the associa-
tion between an aversive stimulus (mild foot shock) and a 
salient environmental cue. Significantly enhanced freezing 
behavior revealed upon re-presentation of the context by one 
genotype rat group compared to the other would have indi-
cated enhanced learning and memory ability. However, as 
our results report no difference in the frequency of freezing 
behavior, we conclude that this memory unit was unaffected 
by the genotype of the rats.
Memory as a cognitive domain can be classified accord-
ing to several criteria, including function (e.g., working vs. 
reference memory), content (e.g. declarative/explicit vs. 
procedural/implicit memory), duration (e.g., immediate or 
short-term vs. long-term or remote memory), nature (asso-
ciative vs. non-associative memory), or motivation (appeti-
tive/reward vs. aversive memory). Hence, to allow for com-
prehensive profiling of mnemonic function, studies aimed at 
assessing differences in performance between ChAT::Cre+ 
versus ChAT::Cre+ rats should utilize a battery of tests that 
cover most, if not all fundamental types of memory pro-
cesses (Savage and Ma 2014).
With evidence suggesting that the HPA-axis may be dys-
functional in children with ADHD (Hong et al. 2003), and 
intriguing findings indicating for a molecular interactive link 
between the brain’s cholinergic systems and the HPA-axis 
neuroendocrine system in modulating cognitive processes 
(Paul et al. 2015), we also determined for possible defective 
HPA-axis activity in ChAT::Cre+ compared to Wt siblings, 
in response to fear conditioning. We assessed circulating 
levels of HPA-axis activity markers. Specifically, the stress 
hormone corticosterone, the main glucocorticoid in rodents 
(Gong et al. 2015), leptin, a 16 kDa protein secreted by adi-
pocytes, which has roles in controlling energy balance as 
well as regulating responses to stress (Haleem 2014), and 
glucose, since cortisol counters insulin by promoting higher 
blood sugar and stimulating gluconeogenesis, for synthesiz-
ing glucose (Maniam et al. 2014). Biomarkers of HPA activ-
ity could not fully explain the effects observed in the trans-
genic rats. In the case of corticosterone, acute stress (foot 
shock) induced increased plasma levels, but in both trans-
genic and Wt rats, to serve as a good biological validator of 
the stress paradigm the rats were subjected to. Exposure to 
the stressor did not alter levels of either leptin or glucose, 
with levels of these markers of HPA activity that were also 
independent of ChAT::Cre− genotype. It is possible that sex 
differences may exist in both the endocrine, cognitive behav-
ioral and stress responses shown by the ChAT::Cre+ rats as 
a result of increased gene copies of VAChT, which translated 
to overexpressed VAChT protein levels. Future work should 
further investigate for such potential sex-specific differences.
The current work differentially analyzed VAChT protein 
and mRNA levels between the transgenic ChAT::Cre+ and 
non-transgenic ChAT::Cre− rats to PFC brain tissue sam-
ples. As a brain region that contains dense cholinergic inner-
vation and outputs, the PFC was deemed to play multiple 
functional roles that particularly relate to the cognitive pro-
cesses that the battery of behavioral tests used in the present 
study were designed for (Wallis 2007; Euston et al. 2012, 
Funahashi 2013). This includes strong arguments that have 
been made that ACh signaling in the PFC is strategically 
uniquely positioned at both the start and terminal end of 
the attentional loop (Sarter et al. 2001; Parikh et al. 2007). 
Through a series of tests, we also undertook anxiety pro-
filing in ChAT::Cre+ versus ChAT::Cre− rats. Again, sev-
eral studies implicated the PFC in anxiety-related behavior, 
with the PFC that was shown to exert integral control (via 
cholinergic reciprocal connections) over the limbic system 
(Kim and Whalen 2009). The strength of the connectivity 
between the PFC and the amygdala has further been corre-
lated with anxiety-like behavior shown in both the OF and 
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EPM (Wei et al. 2010; Delpech et al. 2016). The OF and 
EPM paradigms inherently also evaluate aspects of motor 
control, including locomotion and explorative behavior. A 
comprehensive body of literature implies an important role 
for forebrain ACh in controlling these motor-related aspects, 
as it exerts top-down control over several motor areas via 
reciprocal connections with the PFC (Asaad et al. 2000; 
Miller and Cohen 2001).
However, cholinergic neurotransmission throughout the 
neocortex, but also the hippocampus, amygdala and PPN can 
regulate arousal, learning and attention as well as aspects 
of emotional processing (Inglis et al. 2000, 2001). Hence, 
future work should aim to determine whether the presently 
reported molecular findings pertaining to the PFC is specific 
to this cholinergic brain region, or whether a similar VAChT 
protein and mRNA level expression pattern is evident for 
other brain regions containing cholinergic projection neu-
rons in ChAT::Cre+ compared to ChAT::Cre− rats.
Taken together, the current results reveal that the 
ChAT::Cre rat line overexpresses ‘extra’ copies of a gene 
that functionally control cholinergic signaling. A similar 
effect where the BAC transgene also introduces extra cop-
ies of adjacent genes to the genome is predicted to occur in 
another popular transgenic rat line, namely TH::Cre+ rats 
(Witten et al. 2011), with such rats expressing Cre recom-
binase in tyrosine hydroxylase (TH) neurons. As TH acts as 
the rate-limiting enzyme of catecholamine biosynthesis, this 
rat line has, therefore, been engineered to express Cre in cat-
echolaminergic neurons, including dopaminergic ones, that 
are affected progressively during neurodegenerative diseases 
such as PD, and has, therefore, become particularly useful 
for researching the pathological mechanisms concerning 
PD. Hence, future efforts for developing novel transgenic 
rat systems should utilize strategies for developing cleaner 
transgenic lines by eliminating unwanted genes from modi-
fied BAC DNA that could complicate phenotypic analysis.
The increasing use of genetic models, which include 
transgenic knockout and inbred strains of rodents has high-
lighted the importance of detailed characterization at behav-
ioral and molecular-genetic levels of such rodents being used 
for pursuing research questions. A milestone was reached 
with the development of Cre/lox recombination techniques 
to enable conditional gene targeting in rodents. The technol-
ogy utilizes Cre recombinase that excises a gene segment 
flanked by pairs of specific 34-bp DNA sequences termed 
LoxP recognition sequences (McLellan et al. 2017). Use of 
cell-specific drivers of Cre restricts recombination exclu-
sively to cells where the driver gene is expressed, hence gen-
erating conditional knockout or knockin animals. However, 
the desired tissue specificity may be difficult to apply using 
Cre transgenic lines, with mosaic expression, leakiness of 
the promoter, Cre-induced toxicity, or Cre non-specificity 
that have been reported, all of which could confound the 
original purpose of the experiments. With this regard, sev-
eral published reports have highlighted potential limitations 
posed by the use of ChAT::Cre+ mouse lines in behavio-
ral research (e.g., Crittenden et al. 2014; Chen et al. 2018). 
Hence, our study provides evidence, for the first time, to 
strongly suggest that caution should prevail when interpret-
ing data derived from ChAT::Cre+ rats, for functionally 
modulating cholinergic signaling, particularly in the utili-
zation of cre/lox technology for evaluating the in vivo effects 
of the ChAT gene on performance in cognitive tasks.
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